BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 19053917)

  • 21. Platelet rich fibrin combined with decalcified freeze-dried bone allograft for the treatment of human intrabony periodontal defects: a randomized split mouth clinical trail.
    Agarwal A; Gupta ND; Jain A
    Acta Odontol Scand; 2016; 74(1):36-43. PubMed ID: 25972081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of DFDBA in combination with enamel matrix derivative versus DFDBA alone for treatment of periodontal intrabony defects at 12 months post-surgery.
    Aspriello SD; Ferrante L; Rubini C; Piemontese M
    Clin Oral Investig; 2011 Apr; 15(2):225-32. PubMed ID: 20054593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
    Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
    J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans.
    Sculean A; Barbé G; Chiantella GC; Arweiler NB; Berakdar M; Brecx M
    J Periodontol; 2002 Apr; 73(4):401-8. PubMed ID: 11990441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined periodontal regenerative technique in human intrabony defects by collagen membranes and anorganic bovine bone. A controlled clinical study.
    Paolantonio M
    J Periodontol; 2002 Feb; 73(2):158-66. PubMed ID: 11895280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enamel matrix derivative versus bioactive ceramic filler in the treatment of intrabony defects: 12-month results.
    Leknes KN; Andersen KM; Bøe OE; Skavland RJ; Albandar JM
    J Periodontol; 2009 Feb; 80(2):219-27. PubMed ID: 19186961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral.
    Sculean A; Chiantella GC; Arweiler NB; Becker J; Schwarz F; Stavropoulos A
    Int J Periodontics Restorative Dent; 2008 Apr; 28(2):153-61. PubMed ID: 18546811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study.
    Döri F; Kovács V; Arweiler NB; Huszár T; Gera I; Nikolidakis D; Sculean A
    J Periodontol; 2009 Oct; 80(10):1599-605. PubMed ID: 19792848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects.
    Sculean A; Windisch P; Szendröi-Kiss D; Horváth A; Rosta P; Becker J; Gera I; Schwarz F
    J Periodontol; 2008 Oct; 79(10):1991-9. PubMed ID: 18834256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the effectiveness of enamel matrix derivative, bone grafts, and membrane in the treatment of mandibular Class II furcation defects.
    Jaiswal R; Deo V
    Int J Periodontics Restorative Dent; 2013; 33(2):e58-64. PubMed ID: 23484181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of intrabony defects by different surgical procedures. A literature review.
    Laurell L; Gottlow J; Zybutz M; Persson R
    J Periodontol; 1998 Mar; 69(3):303-13. PubMed ID: 9579616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Periodontal regeneration with a combination of enamel matrix proteins and autogenous bone grafting.
    Cochran DL; Jones A; Heijl L; Mellonig JT; Schoolfield J; King GN
    J Periodontol; 2003 Sep; 74(9):1269-81. PubMed ID: 14584859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass.
    Sculean A; Pietruska M; Arweiler NB; Auschill TM; Nemcovsky C
    J Clin Periodontol; 2007 Jun; 34(6):507-13. PubMed ID: 17451415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autogenous bone graft in conjunction with enamel matrix derivative in the treatment of deep periodontal intra-osseous defects: a report of 13 consecutively treated patients.
    Trombelli L; Annunziata M; Belardo S; Farina R; Scabbia A; Guida L
    J Clin Periodontol; 2006 Jan; 33(1):69-75. PubMed ID: 16367859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of pretreatment clinical parameters on bioactive glass implantation in intrabony periodontal defects.
    Park JS; Suh JJ; Choi SH; Moon IS; Cho KS; Kim CK; Chai JK
    J Periodontol; 2001 Jun; 72(6):730-40. PubMed ID: 11453234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial.
    Paolantonio M; Femminella B; Coppolino E; Sammartino G; D'Arcangelo C; Perfetti G; Perinetti G
    J Periodontol; 2010 Nov; 81(11):1587-95. PubMed ID: 20583915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small versus large particles of demineralized freeze-dried bone allografts in human intrabony periodontal defects.
    Fucini SE; Quintero G; Gher ME; Black BS; Richardson AC
    J Periodontol; 1993 Sep; 64(9):844-7. PubMed ID: 8229619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EDTA gel root conditioning: lack of effect on clinical and radiographic outcomes of intrabony defect treatment with enamel matrix derivative.
    Parashis AO; Tsiklakis K; Tatakis DN
    J Periodontol; 2006 Jan; 77(1):103-10. PubMed ID: 16579710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal class II furcation involvement in mandibular molars. Part II: secondary outcomes.
    Meyle J; Gonzales JR; Bödeker RH; Hoffmann T; Richter S; Heinz B; Arjomand M; Reich E; Sculean A; Jepsen K; Jepsen S
    J Periodontol; 2004 Sep; 75(9):1188-95. PubMed ID: 15515332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of Bio-Oss: a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
    Richardson CR; Mellonig JT; Brunsvold MA; McDonnell HT; Cochran DL
    J Clin Periodontol; 1999 Jul; 26(7):421-8. PubMed ID: 10412845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.